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Abstract
Objective—The current study sought to evaluate patterns of complementary and alternative
medicine (CAM) use in a sample of Latino and Non-Latino white (NLW) children with asthma, to
determine whether parental beliefs about conventional medications and barriers to obtaining these
medications were related to CAM use, and to assess whether CAM use was associated with
decreased adherence to controller medications.
Methods—Participants included 574 families of children with asthma from Non-Latino White,
Puerto Rican, and Dominican backgrounds from RI and from Island Puerto Rico. All parents
completed a brief checklist of barriers to medication use and an assessment of CAM approaches.
A subsample of 259 families had controller medication use monitored objectively for
approximately one month by MDILog (fluticasone propionate), TrackCap (montelukast), or
dosage counter (fluticasone/salmeterol combination).
Results—Prevalence of CAM use was high among Latino families. Perceived barriers to
obtaining medication were related to increased CAM use in Puerto Rican families from RI.
Elevated medication concerns were positively associated with CAM use among NLW and Island
PR families. CAM use was positively related to objective adherence within NLW families, and
unrelated in other groups.
Conclusions—CAM use is common among Latino families with asthma. Among some families,
CAM use may be initiated as a way to cope with barriers to obtaining medication or when parents
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have concerns about conventional medications. Families who report CAM use do not appear to be
substituting CAM for conventional asthma medication.
Keywords
Asthma; Adherence; Complementary and Alternative Medicine
Pediatric asthma is associated with impaired quality of life and increased health care
utilization (1). Minority and disadvantaged populations are disproportionately affected (2).
Latinos of Caribbean have particularly high prevalence, morbidity, and health care
utilization (3). The sources of these disparities are multifaceted and complex, and include
genetics, individual and family beliefs, health care system features, and broad environmental
variables such as housing and pollution (4). Attitudes toward conventional medication use,
and barriers to obtaining prescribed medications, may be modifiable sources of asthma
disparities (5).
National guidelines for asthma management include daily controller medication use to
prevent symptoms and exacerbations for those with chronic asthma (6). Research among
ethnic minorities consistently demonstrates concerns about controller medication use (7; 8),
and lower medication adherence (9). We previously found that controller medication
adherence was low among island Puerto Rican and Latino families in the United States
relative to Non-Latino white families (10). Data indicate greater acceptance of
complementary and alternative medicine (CAM) use among ethnic minority families with
asthma (11). Few studies, however, have examined how preference for CAM may relate to
adherence to prescribed controller medications (12).
CAM is defined as “a group of diverse medical and health care systems, practices, and
products that are not generally considered part of conventional medicine” (13). Prevalence
of CAM use among families of children with asthma ranges from 33–89% across studies
(14). Rates of CAM use for ethnic minority families with asthma range between 48–89%,
depending upon ethnicity (15–16). Reasons for CAM use in ethnic minority families are
likely multifaceted. In earlier work examining CAM use among Puerto Rican families,
patterns of acculturation were related to medication adherence, with higher adherence
among families whose parents reported a bicultural orientation (16). CAM use may be
related to families’ broader ethnocultural belief systems regarding health and illness (17).
Potential Relation of CAM Use to Beliefs and Barriers
Parental beliefs and concerns about conventional asthma medication may be associated with
CAM use. Studies including Latino (5;8) and mixed ethnicity samples (7;18) indicate that
parents often have concerns surrounding the use of conventional asthma medication,
including immediate side-effects, medication dependence, and long-term effects. These
concerns are related to lower reported asthma medication adherence (7) and higher
likelihood of uncontrolled asthma (19). Studies relating parental medication beliefs and
child asthma medication adherence, however, have used predominantly NLW samples and
have not assessed CAM use (18).
Ethnic minority families may be more likely to face barriers to obtaining prescription asthma
medications (20). These include financial burden, socio-cultural factors (e.g., limited
English proficiency), and practical constraints (e.g., transportation difficulties) (21). For
instance, CAM use has been found to be higher among uninsured families and those who
perceived financial barriers to asthma care (22). In one report from the sample presented in
this paper, barriers to medication use were high among Island PR families relative to Latino
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and non-Latino white families (5). These barriers also may play a role in greater CAM use
and lower adherence to conventional asthma medications.
CAM and Adherence to Asthma Medication
Latino parents of children with asthma may substitute CAM for asthma medications to
prevent symptoms (8). CAM may also be used as a first line treatment for episodes (15).
Research regarding CAM use and adherence to controller medications; however, has
produced mixed findings. Positive caregiver beliefs surrounding CAM were linked to risk
for self-reported nonadherence to asthma medication in a largely minority sample (23).
Alternatively, parent report of child medication adherence was not associated with initiation
of CAM within a predominantly NLW sample (12). To date, no studies have examined
whether CAM use is associated with asthma medication adherence using objective
electronic monitoring methods, and whether that association differs by ethnic group.
The Current Study
In a prior report including this sample, we found that adherence to controller medications
differed by ethnic group, with the lowest adherence among families of children from Island
Puerto Rico, and the highest among NLW families (10). Rates of CAM use; however, and
the role of CAM in relation to medication adherence have not yet been reported. In the
current study, we evaluated CAM use in a sample of families of children with asthma from
NLW, Puerto Rican, and Dominican backgrounds from RI and Island PR, to evaluate
patterns of overall CAM use by ethnic group. We also sought to determine whether parental
beliefs about conventional asthma medications and barriers to obtaining medications were
related to CAM use, and if language preference and years living outside the US (proxies for
acculturation) were associated with CAM use among our mainland Latino subgroups (Puerto
Rican and Dominican). Lastly, we evaluated whether CAM use was associated with
objective adherence to asthma controller medications. We hypothesized that: 1) CAM use
would be higher in families of Puerto Rican and Dominican descent, relative to NLW
families, 2) negative beliefs surrounding conventional asthma medication and barriers to
asthma medication use would be related to greater CAM use for all families, 3) lower levels
of acculturation would be associated with reports of CAM use for mainland Latino families,
and 4) increased CAM use would be related to lower levels of adherence to controller
medications, but only among Latino families (12;23).
Method
Participants were a subset from a larger study (N = 805) (24) evaluating mechanisms
underlying pediatric asthma disparities between Latino and NLW groups. Previous
published work from this study has addressed contributing factors to variations in asthma
outcomes across Latino and NLW children, such as asthma severity (25), asthma symptom
perception (26), and objective rates of controller medication use (10).
Data collection occurred in Puerto Rico (PR) and Rhode Island (RI). Participants (aged 7–16
years) were recruited from hospital-based and community primary care clinics, community
events, and asthma classes. Asthma diagnosis was confirmed through medical history,
physical examination, and spirometry; those with complicating respiratory conditions were
excluded. Puerto Rican families with a child with asthma were eligible at the PR site.
Ethnicity in RI was determined by parent report, and caregivers of Puerto Rican, Dominican,
or NLW ethnicity were eligible. For this report, we include only children with persistent
asthma (due to greater medication need), and those that completed an evaluation of CAM
use.
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Procedure
Data collection occurred in four study visits over the course of approximately four months.
Visits were generally conducted in the home by research assistants; the clinic visit was
conducted in a hospital setting by a study physician or nurse practitioner. Informed consent
and demographic information were obtained at enrollment. Data included in this study were
collected at the second visit, typically 1–2 weeks after enrollment. During this visit, the
family was interviewed regarding asthma management strategies using a standardized
interview (27), completed surveys, and was oriented to adherence monitoring procedures.
Adherence devices were collected approximately five weeks later. Families were
compensated for participation. The protocol was approved by institutional review boards at
both sites.
Measures
Asthma Severity—Asthma severity was evaluated by a study clinician during the clinic
visit, based on physical exam, history, report of symptom frequency, pre-albuterol FEV1,
and current controller medication dose. The four levels of asthma severity were “Mild
Intermittent”, “Mild Persistent”, “Moderate Persistent”, and “Severe Persistent”, consistent
with guidelines in place at the time of the study (28).
Medication Beliefs—Parents completed a ten-item self-report measure (29) to assess
parental beliefs about asthma medication, resulting in index scores of perceived medication
necessity (e.g., the medicines are necessary for the child’s health) and medication concerns
(e.g., dependence, side effects).
Barriers to Filling Prescriptions—Potential barriers to filling prescriptions were
evaluated using an 8-item list devised for the larger study (20; 23). Items represented health
care system and contextual barriers such as cost, transportation problems, language barriers,
and pharmacy wait-time.
Acculturation—Language preference was coded as preferred language of research
interview for RI Puerto Rican and Dominican families; this categorical variable and the
number of years the caregiver had lived outside of the mainland US were used as proxies for
acculturation.
CAM Checklist—CAM use was assessed with the CAM Checklist, developed for the
larger study to assess CAM use among Latino and NLWs (23), administered in the context
of an established asthma management interview (27). Items were originally derived through
literature review (17), ongoing research with the target population (30) and a series of focus
groups with families from different ethnic subgroups. A list of asthma treatment strategies
reported by families was independently reviewed by experts in asthma management and
cultural issues in RI and PR. Participants indicated whether or not they had utilized various
types of CAM to treat their children’s asthma.
Medication Adherence Monitoring—A subset of participants who were prescribed
asthma controller medications that could be monitored objectively participated in the
medication adherence monitoring protocol. Objective adherence monitoring in the larger
study is described in detail elsewhere (10). In brief, adherence was monitored for controller
medications in three distinct ways. Adherence to oral montelukast was monitored using the
TrackCap MEMS monitor (AARDEX), which is a replacement pill bottle with an electronic
cap that registers the date and time of each opening. Adherence to inhaled fluticasone was
monitored using The MDIlog II (Westmed), a small electronic device attached to an inhaler
“sleeve” that fits over the inhaler, and records the date and time of inhaler actuation with
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inhalation. Adherence to fluticasone/salmeterol combination medication (diskus) was
monitored by using a standard protocol to record dosage counter readings at the beginning
and end of the monitoring period.
Adherence was monitored for a minimum of 28 days. Data were inspected and cleaned
according to standard procedures (31). Seventy-five cases were eliminated from the
adherence analysis for a range of reasons (see (10) for specific details regarding device loss
and data cleaning), resulting in 277 usable cases. Of these, 259 families had also completed
the CAM Checklist. Data used in adherence analyses were available from 77 island PR
children, 51 RI PR children, 56 RI DR children, and 75 RI NLW children.
Adherence estimates were calculated as total doses per day/prescribed doses per day. For
participants on more than one monitored medication, the adherence estimate represented the
average of the two adherence measurements. Given that participants could be prescribed
more than one monitored medication, and medication adherence is known to differ by
medication type (32; 33), a categorical variable was constructed to represent each
medication combination encountered in this study, namely montelukast alone (61.4%),
fluticasone alone (7.7%), fluticasone/salmeterol combination (8.9%), fluticasone and
montelukast (8.5%), and fluticasone/salmeterol combination with montelukast (13.5%).
Overview of Analyses
Chi square analyses were conducted to determine whether the prevalence of CAM use and
CAM types differed by site/ethnicity. T tests, chi square analyses, and logistic regressions
were conducted to examine whether acculturation variables, caregiver perceived barriers to
prescription medication, and beliefs about asthma medication were predictive of CAM use
(yes/no). The total number of barriers to prescription medication and the medication
necessity and concerns subscales were entered simultaneously in each regression model.
Adherence estimates, which represent proportional data, were adjusted using a probit
transformation prior to analysis. Regression analyses controlling for covariates, specifically
the child’s asthma severity level, medication monitoring type (e.g., MDIlog, TrackCap, or
dosage counter; 32), and child age (31) were conducted to determine whether reported CAM
use was associated with objective medication adherence.
Results
Participants
From an initial sample of 805 families, the current sample included children with persistent
asthma who completed the CAM checklist. This resulted in a sample of 574 families across
sites, including 267 island PR children, 92 RI PR children, 107 RI DR children, and 108
NLW children in RI (Table 1). A subsample of 259 children also had objective adherence
data available (see Figure 1).
Prevalence of overall CAM use by Site/Ethnicity
Reported CAM use differed by site and ethnicity (χ2 (3, N = 574) = 97.01, p < .001). Island
PR families reported the highest rates of CAM use (73%) compared to RI PR (51%), RI DR
(62%), and NLW families (19%). Subsequent analyses were conducted within groups.
Prevalence of CAM Type across Site/Ethnicity
Reported types of CAM also differed by site and ethnicity; specifically, mind-body
interventions (χ2 (3, N = 574) = 81.70, p < .001), biologically-based therapies (χ2 (3, N =
574) = 91.63, p < .001), and body-based methods (χ2 (3, N = 574) = 101.30, p < .001) all
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differed by our site/ethnicity groups (see Figure 2). Island PR families reported the highest
rates of CAM use across the three types, followed by RI DR, RI PR, and NLW families.
Data regarding use by CAM item and type are presented in Table 2.
Association of CAM Use to Acculturation Variables, Perceived Barriers, and Medication
Beliefs
Acculturation variables—The number of years caregivers reported living outside of the
US was unrelated to CAM use across groups. Language preference was only related to CAM
use in RI DR families, χ2(1, N = 125) = 5.34, p = .021. CAM use was higher among Spanish
speaking (57.6%) than English speaking (5.6%) RI DR families.
Perceived barriers to prescription medication—A higher number of perceived
barriers to prescription medication use was associated with CAM use among RI PR families,
β = .76, SE = .39, p = .050 (Table 3), but not among other groups.
Beliefs about medication—Elevated medication concerns were associated with CAM
use among Island PR (β = .50, S, .22, pE = .026) and RI NLW (β = .85, S, .39, pE = .030; see
Table 3) families, but not among RI PR and RI DR families. Medication necessity was not
related to CAM use within any group.
Relation of CAM to adherence
CAM use was related to increased adherence to controller medications within NLW
families, β = .23, p = .047 (Table 4). For children and families from Latino backgrounds,
CAM use was not related to controller medication adherence.
Discussion
Pediatric asthma continues to represent a source of health disparities between Latinos and
NLWs (1;3). Given that adherence to controller medications remains challenging for many
families (31; 34), and for minority families in particular (10; 32; 33), cognitive and
behavioral variables such as attitudes toward medication use, barriers to obtaining
medications, and preference for CAM use represent potentially modifiable intervention
targets. In our sample, nearly three quarters of Island PR and over half of RI Latino families
reported some CAM use, whereas only one fifth of NLW families reported using CAM.
Results are consistent with previous research demonstrating a high prevalence of CAM use
in Latino families (17, 30).
Self-report of CAM use was associated with language preference among our Dominican
group, suggesting that lower-acculturated families were more likely to use CAM. CAM use
was modestly associated with beliefs and barriers to medication use, and only for certain
groups. Among our RI PR group, barriers to obtaining medications were modestly
associated with CAM use. It is possible that these families may turn to CAM when they
encounter barriers to obtaining asthma medication. Due to financial strain, barriers to
obtaining medications may also serve as barriers to obtaining CAM (e.g., rubs available at
the pharmacy, teas). Elevated medication concern was positively associated with CAM use
only in the Island PR and NLW groups. Parental concerns could be a factor in the high
prevalence rate of CAM use within the Island PR group, and similar concerns may play a
role among NLW families. Specific factors that may predict CAM use not measured in this
report bear further study, including ease of access to culturally sanctioned CAM methods,
such as through a bodega or herbalist in one’s neighborhood. A more nuanced examination
of acculturation and immigration factors (e.g., cultural identity), health-care system factors
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(e.g., consistent asthma care provider), and CAM use in relation to conventional medication
use is warranted.
We previously noted the lowest rates of adherence to controller medications among Island
PR families, and the highest rates among RI NLW families (10). Our results suggest that
factors other than CAM use may account for this effect. CAM use was unrelated to
medication adherence among our Latino families in both RI and PR. These findings are
consistent with previous research (12), indicating no relation between child medication
adherence and CAM use in a predominantly NLW sample.
CAM use was positively related to medication adherence among NLW families in our
sample. Some families who are concerned about their child’s asthma may try multiple
strategies (both conventional and CAM) to manage symptoms. For Latino families in RI and
PR this relationship is less clear. CAM use may be related to medication use at multiple
levels, and may change over time due to family circumstances. For example, families may
hesitate to fill a prescription once received, or use it intermittently according to their
financial circumstances. If a medication has run out and they do not have the resources for a
refill, praying or using oils may seem a viable alternative if useful in the past. Overall, these
results reflect that the relationship between CAM use and use of conventional medications is
complex, and CAM use may not indicate poor medication adherence. Research is needed to
clarify dynamic, multi-level factors that may predict CAM use and use of conventional
asthma medications among specific ethnic groups.
A number of study limitations bear mention. Our checklist was developed to assess CAM
use specific to Latinos, and may have missed certain strategies more typically implemented
by NLW families (e.g., chiropractic care; 35). Use of objective measures of medication
adherence is a strength; however, we were only able to assess adherence to medications that
had been prescribed and filled, and hence did not capture under prescription of controller
medications, or nonadherence through failure to fill prescriptions. Qualitative work may be
necessary to fully understand how families make decisions about CAM use, and how this
affects patterns of filling and using conventional medications.
Although study personnel were fully bilingual and trained in cultural sensitivity surrounding
asthma practices, it is possible that RI Latino families underreported CAM use due to
perceptions that these strategies might be less acceptable in the dominant US culture.
Additionally, administration of measures regarding asthma management prior to adherence
data collection may have “primed” families to be more adherent; however, it is not clear this
would lead to group differences. Group sample sizes were modest, which may have limited
our power to find effects. Lastly, our sample was recruited based on likely asthma diagnosis
and through convenience sampling, and hence may not adequately represent families with
children under diagnosed or undertreated for asthma.
There is an increasing emphasis on culturally-centered care in the treatment of children with
asthma (36). Incorporating the cultural beliefs and practices of families into asthma-related
care can improve asthma outcomes compared to standard treatment approaches (37).
Following the Awareness-Assessment-Negotiation model (38) may aid clinicians in
integrating these findings into patient care. According to this model, clinicians should
become aware of commonly held beliefs and practices among cultures for which they
provide care, assess these beliefs and practices, and find ways to integrate beliefs and
practices into patient care. Clinicians should be encouraged to discuss and assess CAM use
and how it may be related to concerns regarding use of conventional asthma medications
and family-specific barriers to medication use (17). Culturally-centered care may enhance
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the patient-provider relationship and ultimately improve asthma management among
families of children at most risk for asthma morbidity.
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What’s New
This study evaluates associations between CAM use and parental beliefs about
conventional medications and barriers to obtaining these medications among Latino and
non-Latino white (NLW) families of children with asthma, and how this use relates to
medication adherence. CAM use was positively related to adherence in NLWs, and
unrelated among Latinos.
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Figure 1.
Participant Flow
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Figure 2. Percentages of CAM Type by Site/Ethnicity
Note. PR = Puerto Rico; DR = Dominican Republic; NLW = Non-Latino White. * p < .001
from Chi-square analysis comparing CAM type by site/ethnicity.
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Table 1
Demographics of children and caregivers
Total Sample (n = 574) No Adherence Data
Subsample (n = 315)
Adherence Data
Subsample (n = 259)
p
Child ethnicity/site, n (%) <.001
 Island PR 267 (46.5%) 190 (60.3%) 77 (29.7%)
 RI PR 92 (16%) 41 (13.0%) 51 (19.7%)
 RI DR 107 (18.6%) 51 (16.2%) 56 (21.6%)
 RI NLW 108 (18.8) 33 (10.5%) 75 (29.0%)
Child age, M (SD) 10.54 (2.48) 10.73 (2.51) 10.32 (2.43) .053
Asthma severity, n (%) <.001
 Mild persistent 209 (36.4%) 132 (41.9%) 77 (29.7%)
 Moderate persistent 231 (40.2%) 143 (45.4%) 88 (34.0%)
 Severe persistent 134 (23.3%) 40 (12.7%) 94 (36.3%)
Child gender, female, n (%) 242 (42.2%) 133 (42.2%) 109 (42.1%) .974
Caregiver identity, n (%) .051
 Biological mother 545 (94.9%) 299 (94.9%) 246 (95.0%)
 Biological father 12 (2.1%) 3 (1.0%) 9 (3.5%)
 Other female relative 16 (2.7%) 12 (3.8%) 4 (1.6%)
 Other male relative 1 (.2%) 1 (.2%) 0 (0%)
Below poverty threshold, n (%) 303 (52.8%) 59.4% 116 (44.8%) <.001
Combined caregiver years of education, M
(SD)
12.72 (2.69) 12.59 (2.67) 12.88 (2.71) .118
Spanish language preference, n (%) .617
 RI PR 52 (56.5) 20 (6.3%) 32 (12.4%)
 RI DR 92 (86.0) 45 (14.3%) 47 (18.1%)
Years caregiver lived outside US, M (SD)
 RI PR 13.58 (11.74) 12.31 (12.41) 14.63 (11.18) .352
 RI DR 21.51 (10.25) 21.78 (9.72) 21.26 (10.80) .795
Note. PR = Puerto Rico; DR = Dominican Republic; NLW = Non-Latino White. Comparisons between adherence subsamples made using chi-
square or t tests.
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